Right ventricular outflow tract obstruction natural history: Difference between revisions

	Right ventricular outflow tract obstruction Microchapters
Home
Patient Information
Overview
Anatomy of Pulmonary Valve
Classification
Pulmonary valve stenosis
Pulmonary subvalvular stenosis
Pulmonary supravalvular stenosis
Pulmonary atresia
Pathophysiology
Causes
Differentiating Right ventricular outflow tract obstruction from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
Chest X Ray
Echocardiography
Cardiac Catheterization
Pulmonary Angiography
Treatment
Indications For Surgery
Surgery
Pre-Operative A/P
Post-Operative A/P
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pulmonary artery conduits/Prosthetic Valves
Double-Chambered Right Ventricle
Case Studies
Case #1
Right ventricular outflow tract obstruction natural history On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Right ventricular outflow tract obstruction natural history
CDC on Right ventricular outflow tract obstruction natural history
Right ventricular outflow tract obstruction natural history in the news
Blogs on Right ventricular outflow tract obstruction natural history
Directions to Hospitals Treating Right ventricular outflow tract obstruction natural history
Risk calculators and risk factors for Right ventricular outflow tract obstruction natural history

VisualWikitext

Revision as of 19:30, 27 January 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Natural History, Complications, and Prognosis

Natural History

The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
The symptoms of (disease name) typically develop ___ years after exposure to ___.
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Complications

Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]

Prognosis

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
[Subtype of disease/malignancy] is associated with the most favorable prognosis.
The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

Template:WH Template:WS

@@ Line 3: / Line 3: @@
 {{CMG}}
-Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+==Overview==
+If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
+OR
+Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
-==Overview==
+OR
-==Natural History==
+Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
+==Natural History, Complications, and Prognosis==
-Among patients with moderate to severe pulmonic stenosis (PS), the gradient often progressively increases.  In patients with mild PS the gradient often remains stable.
+===Natural History===
+*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
+*The symptoms of (disease name) typically develop ___ years after exposure to ___.
+*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
-==Complications==
+===Complications===
+*Common complications of [disease name] include:
+**[Complication 1]
+**[Complication 2]
+**[Complication 3]
-==Prognosis==
+===Prognosis===
-The prognosis among patients with PS who have reached adulthood without right ventricular failure or symptoms is reported to be good with minimal risk of [[endocarditis]], [[right ventricular]] failure or death.
+*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
+*Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
+*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
+*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
+*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
 ==References==
-{{reflist|2}}
+{{Reflist|2}}
-{{WikiDoc Help Menu}}
+{{WH}}
-{{WikiDoc Sources}}
+{{WS}}
-[[Category:Needs content]]
+[[Category: (name of the system)]]
-[[Category:Disease]]
-[[Category:Cardiology]]
-[[Category:Congenital heart disease]]
-[[Category:Pediatrics]]